Camurus AB (CAMX) - Total Liabilities

Latest as of December 2025: Skr504.56 Million SEK ≈ $54.30 Million USD

Based on the latest financial reports, Camurus AB (CAMX) has total liabilities worth Skr504.56 Million SEK (≈ $54.30 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Camurus AB - Total Liabilities Trend (2011–2025)

This chart illustrates how Camurus AB's total liabilities have evolved over time, based on quarterly financial data. See CAMX working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Camurus AB Competitors by Total Liabilities

The table below lists competitors of Camurus AB ranked by their total liabilities.

Company	Country	Total Liabilities
Multistrada Arah Sarana Tbk JK:MASA	Indonesia	Rp116.72 Million
Fermi Inc. NASDAQ:FRMI	USA	$317.44 Million
Xiamen Amoytop Biotech Co Ltd SHG:688278	China	CN¥453.98 Million
Kimberly-Clark de México S. A. B. de C. V MX:KIMBERA	Mexico	MX$43.60 Billion
Hubei TKD Crystal Electn SHG:603738	China	CN¥365.58 Million
ATHENS INTERNATIONAL AIRPORT S. AT:AIA	Greece	€1.41 Billion
Loomis AB ser. B ST:LOOMIS	Sweden	Skr25.51 Billion
Beam Therapeutics Inc NASDAQ:BEAM	USA	$316.36 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Camurus AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Camurus AB stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	12.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	10.15	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Camurus AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Camurus AB (2011–2025)

The table below shows the annual total liabilities of Camurus AB from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr504.56 Million ≈ $54.30 Million	+7.97%
2024-12-31	Skr467.33 Million ≈ $50.29 Million	+12.66%
2023-12-31	Skr414.82 Million ≈ $44.64 Million	+33.46%
2022-12-31	Skr310.82 Million ≈ $33.45 Million	+33.40%
2021-12-31	Skr232.99 Million ≈ $25.07 Million	+18.47%
2020-12-31	Skr196.66 Million ≈ $21.16 Million	+40.06%
2019-12-31	Skr140.41 Million ≈ $15.11 Million	+24.92%
2018-12-31	Skr112.40 Million ≈ $12.10 Million	+23.61%
2017-12-31	Skr90.93 Million ≈ $9.79 Million	+20.67%
2016-12-31	Skr75.36 Million ≈ $8.11 Million	-57.13%
2015-12-31	Skr175.79 Million ≈ $18.92 Million	+108.75%
2014-12-31	Skr84.21 Million ≈ $9.06 Million	+36.69%
2013-12-31	Skr61.61 Million ≈ $6.63 Million	+258.30%
2012-12-31	Skr17.20 Million ≈ $1.85 Million	-77.46%
2011-12-31	Skr76.30 Million ≈ $8.21 Million	--

About Camurus AB

ST:CAMX Sweden Biotechnology

Market Cap

$3.33 Billion

Skr30.95 Billion SEK

Market Cap Rank

#4722 Global

#59 in Sweden

Share Price

Skr519.00

Change (1 day)

-2.63%

52-Week Range

Skr437.40 - Skr733.50

All Time High

Skr733.50